Factor V Leiden and prothrombin gene 20210A variant in neonatal thromboembolism and in healthy neonates and adults: A study in a single center

Pediatric Hematology and Oncology

Volumn 20, Issue 8, 2003, Pages 627-634

  Atasay, Begüm ^a,b   Arsan, Saadet ^a   Günlemez, Ayla ^a   Kemahli, Sabri ^a   Akar, Nejat ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Neonate; Prothrombotic mutations; Thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTEIN C; PROTHROMBIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENE MUTATION; GENETIC DISORDER; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; HOMOZYGOTE; HUMAN; INCIDENCE; MUTATIONAL ANALYSIS; NEWBORN; NEWBORN DISEASE; PREVALENCE; PROTEIN C DEFICIENCY; PROTEIN VARIANT; RISK ASSESSMENT; RISK FACTOR; SYMPTOM; THROMBOEMBOLISM; THROMBOPHILIA; THROMBOSIS;

EID: 0344012153     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/08880010390243059     Document Type: Article

References (20)

1. Nowak-Göttl U, Kosch A, Schlegel N. Thromboembolism in newborns, infants and children. Thromb Haemost. 2001;86:464-474.
2. David M, Andrew M. Venous thromboembolic complications in children. J Pediatr. 1993;123:337-346.
3. Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics. 1995;96:39-43.
4. Nowak-Göttl U, von Kries R, Gobel U. Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed. 1997;76:F163-F167.
5. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64-67.
6. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698-3703.
7. Akar N, Misirlio_lu M, Akar E, Avcu F, Yalçin A, Sözüöz A. Prothrombin gene 20210A mutation in the Turkish population. Am J Hematol. 1998;58:249.
8. Kemahli S, Alhenc-Gelas M, Gandrille S, Aiach M, Akar N, Cin_. Homozygous protein C deficiency with a double variant His 202 to Tyr and Ala 346 to Thr. Blood Coag Fibrinol. 1998;9:351-354.
9. Andrew ME, Monagle P, de Veber G, Chan A. Thromboembolic diseases and antithrombotic therapy in newborns. In: American Society of Hematology Education Program Book. 2001;1:358.
10. Nowak-Göttl, Koch HG, Aschka I, et al. Resistance to activated protein C in children with venous and arterial thromboembolism. Br J Heamatol. 1996;92:992-998.
11. Lawson SE, Butler D, Enayat MS, Williams MD. Congenital thrombophilia and thrombosis: a study of a single centre. Arch Dis Child. 1999;81:176.
12. de Veber G, Monagle P, Chan A. Prothrombotic disorders in infants with cerebral thromboembolism. Arch Neurol. 1998;55:1539.
13. Hagstrom JN, Walter J, Bluebond-Lagner R. Prevelance of the factor V leiden mutation in children and neonates with thromboembolic disease. J Pediatr. 1998;133:777.
14. Gürgey A, Mesci L, Renda Y, Olcay, L, Koçak N, Erdem G. Factor V Q506 mutation in childeren with thrombosis. Am J Hematol. 1996;53:37.
15. Schobess R, Junker R, Auberger K, Münchow N, Burdach S, Nowak-Göttl U. Factor V G1691 A and prothrombin G20210A in childhood spontaneous venous thrombosis: evidence of an age dependent thrombotic onset in carriers of factor V G1691 A and prothrombin G20210A mutation. Eur J Pediatr. 1999;158(Suppl 3):S105-S108.
16. Akar N, Akar E, Dalgin G, Sözüöz A, Ömürlü K, Cin S. Frequency of factor V(1691GA) mutation in Turkish population. Thromb Haemost. 1997;78:1527-1529.
17. Akar N. Frequency of hereditary thrombophilia in Turkish population (effect of the age and genetic polymorphisms on the occurrence of thrombosis). Turk J Haematol. 2000;17:3(Suppl):228-229.
18. Arsan S. Clinical aspects of neonatal thrombosis. Turk J Haematol. 2000;17:3(Suppl):230-233.
19. Rees DC, Cos M, Clegg JB. World distribution of factor V Leiden. Lancet. 1995;346:1133-1134.
20. Herrmann FH, Koesling M, Schroder W, et al. Prevelance of factor V Leiden in various populations. Genet Epidemiol. 1997;14:403-411.